[Source: US Centers for Disease Control and Prevention (CDC), MMWR Morbidity and Mortality Weekly Report, full page: (LINK). Summary, edited.]
Notes from the Field: Effects of the COVID-19 Response on Tuberculosis Prevention and Control Efforts — United States, March–April 2020
Weekly / July 24, 2020 / 69(29);971–972
Ann M. Cronin1; Shanica Railey, MPH1; Diana Fortune2; Donna Hope Wegener, MA2; Justin B. Davis, MPH1
Corresponding author: Ann M. Cronin, AXC2@cdc.gov.
1Division of Tuberculosis Elimination, National Center for HIVAIDS, Viral Hepatitis, STD, and TB Prevention, CDC; 2The National TB Controllers Association, Smyrna, Georgia.
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Suggested citation for this article: Cronin AM, Railey S, Fortune D, Wegener DH, Davis JB. Notes from the Field: Effects of the COVID-19 Response on Tuberculosis Prevention and Control Efforts — United States, March–April 2020. MMWR Morb Mortal Wkly Rep 2020;69:971–972. DOI: http://dx.doi.org/10.15585/mmwr.mm6929a4
___
CDC’s Division of Tuberculosis Elimination (DTBE) funds 61 state, local, and territorial tuberculosis programs in the United States through the TB Elimination and Laboratory cooperative agreement. Recipients report data to CDC on indicators that measure progress toward TB elimination and performance of essential TB program activities. After the first U.S. case of coronavirus disease 2019 (COVID-19) was reported on January 20, 2020 (1), CDC project officers were informed by these grantees that program personnel (including those positions funded through the CDC cooperative agreement and state or local budgets) would be deployed for their jurisdictions’ COVID-19 response.
(…)
–
Keywords: SARS-CoV-2; COVID-19; Tuberculosis; USA.
——
